Results 331 to 340 of about 14,184,553 (374)

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

Nature Network Boston, 2006
C. Manno, V. Arruda, G. Pierce, B. Glader, M. Ragni, J. Rasko, M. Ozelo, K. Hoots, P. Blatt, B. Konkle, M. Dake, R. Kaye, M. Razavi, A. Zajko, J. Zehnder, H. Nakai, A. Chew, D. Leonard, D. Leonard, J. F. Wright, R. Lessard, J. Sommer, M. Tigges, D. Sabatino, A. Luk, Haiyan Jiang, F. Mingozzi, L. Couto, H. Ertl, K. High, K. High, M. Kay   +31 more
semanticscholar   +1 more source

Immunologic studies of factor IX (christmas factor) I. Counterimmunoelectrophoresis method for factor IX antigen

Thrombosis Research, 1978
Abstract A precipitating monospecific antiserum for factor IX antigen was produced by immunization of rabbits with a partly purified factor IX and solid-phase immunoadsorption. The monospecific antiserum was used to determine the presence of factor IX antigen in hemophilia B and normal plasmas by a counterimmunoelectrophoresis method.
openaire   +3 more sources

Immunologic Studies of Factor IX (Christmas Factor)

British Journal of Haematology, 1978
A solid‐phase two‐site immunoradiometric assay has been developed which measures factor IX antigen levels as low as 0.0004 u per ml of plasma. In normal individuals, the factor IX antigen level correlated with the factor IX procoagulant level. In haemophilia B, 14 patients had markedly reduced antigen levels (<0.06 u/ml) and five had normal levels (&
openaire   +3 more sources

Factor-IX

Reactions weekly

semanticscholar   +2 more sources

Factor IX Concentrates [PDF]

Thrombosis and Haemostasis, 1975
openaire   +2 more sources

Standardization of assays of factor VIII and factor IX

La Ricerca in Clinica e in Laboratorio, 1990
The development of international standards over the last 15-20 years has led to improved interlaboratory agreement on assays of factor VIII and factor IX. In the most recent international collaborative study, the coefficient of variation for one-stage assays (26 laboratories) was 5.6%.
openaire   +3 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Determination of Activated Factor IX in Factor IX Concentrates with a Chromogenic Substrate

Thrombosis Research, 1998
Jörg Stürzebecher, Dagmar Prasa
openaire   +3 more sources

Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B

Haemophilia, 2018
C. Wang, G. Young
semanticscholar   +1 more source

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly